Overview
Peter Coffey practices in London, United Kingdom. Mr. Coffey is rated as a Distinguished expert by MediFind in the treatment of Autosomal Dominant Vitreoretinochoroidopathy. His top areas of expertise are Autosomal Dominant Vitreoretinochoroidopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Leber Congenital Amaurosis.
His clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Autosomal Dominant Vitreoretinochoroidopathy.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Autosomal Dominant Vitreoretinochoroidopathy
- Advanced
- Age-Related Macular Degeneration (ARMD)
- Late-Onset Retinal DegenerationMr. Coffey isAdvanced. Learn about Late-Onset Retinal Degeneration.
- Experienced
- ChoroideremiaMr. Coffey isExperienced. Learn about Choroideremia.
- Leber Congenital AmaurosisMr. Coffey isExperienced. Learn about Leber Congenital Amaurosis.
- Retinitis PigmentosaMr. Coffey isExperienced. Learn about Retinitis Pigmentosa.
- Retinopathy Pigmentary Mental Retardation